clinical trials for retatrutide A new weight-loss drug called is generating excitement after trial participants lost an average of 30% of their body weight, results that rival or even exceed weight-loss surgery. Researchers also retatrutide clinical trial news Retatrutide:

Lack of sleep (11) is a known cause of weight gain and you should not take this medication if it interferes with your ability to sleep

And from the start of this year, basically until pretty much the minute I started with Wegovy, I was having a really fun time sleeping around

It acts as an antifoaming agent to break up trapped bubbles and relieve abdominal pressure

CCR6 has a non-redundant role in the development of inflammatory bowel disease

A study comparing adherence between people with T2D that use insulin and those using GLP-1s found that insulin users had an adherence level of around 90% compared with around 74% for those using GLP-1s (both oral and injectable versions).9 For those using GLP-1s for weight loss, injections are a choice

With the rise of GLP-1 receptor agonists, we wanted to explore whether these treatments could reduce disease burden using real-world claims data. Researchers used propensity scores to match the groups with each other based on age, sex, race and comorbidities (type 2 diabetes, asthma, essential hypertension, hypercholesterolemia, hypertriglyceridemia and BMI)